{"id":"https://openalex.org/W2186436627","doi":"https://doi.org/10.1002/jlb.43.3.224","title":"Effects of Adherence, Activation and Distinct Serum Proteins on the In Vitro Human Monocyte Maturation Process","display_name":"Effects of Adherence, Activation and Distinct Serum Proteins on the In Vitro Human Monocyte Maturation Process","alternate_titles":[],"publication_year":1988,"publication_date":"1988-03-01","ids":{"openalex":"https://openalex.org/W2186436627","doi":"https://doi.org/10.1002/jlb.43.3.224","mag":"2186436627","pmid":"https://pubmed.ncbi.nlm.nih.gov/2830357"},"language":"en","primary_location":{"id":"doi:10.1002/jlb.43.3.224","doi":"https://doi.org/10.1002/jlb.43.3.224","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jlb.43.3.224","pdf_url":null,"source":{"id":"https://openalex.org/S199011235","display_name":"Journal of Leukocyte Biology","issn_l":"0741-5400","issn":["0741-5400","1938-3673"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Leukocyte Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2186436627"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yukio Akiyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yukio Akiyama","raw_affiliation_strings":["Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Griffith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Griffith","raw_affiliation_strings":["Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032984402","display_name":"Paul J. Miller","orcid":"https://orcid.org/0000-0003-2742-8560","observed_orcids":["https://orcid.org/0000-0003-2742-8560"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Miller","raw_affiliation_strings":["Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024160900","display_name":"George W. Stevenson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G W Stevenson","raw_affiliation_strings":["Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030757263","display_name":"Stacy Lund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stacy Lund","raw_affiliation_strings":["Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002607069","display_name":"Dorothy J. Kanapa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D J Kanapa","raw_affiliation_strings":["Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113605699","display_name":"Henry C. Stevenson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henry C Stevenson","raw_affiliation_strings":["Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations Section, Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":2.7857,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.90856473,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"43","issue":"3","first_page":"224","last_page":"231"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monocyte-macrophage-differentiation","display_name":"monocyte-to-macrophage differentiation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/monocyte-maturation","display_name":"monocyte maturation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/serum-proteins","display_name":"serum proteins","score":0.8880000114440918},{"id":"https://openalex.org/keywords/igg","display_name":"IgG","score":0.843999981880188},{"id":"https://openalex.org/keywords/fc-receptors","display_name":"Fc receptors","score":0.5979999899864197},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.75},{"id":"https://openalex.org/keywords/fibronectin","display_name":"fibronectin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cell-adhesion","display_name":"cell adhesion","score":0.6639999747276306},{"id":"https://openalex.org/keywords/serum-free-medium","display_name":"serum-free medium","score":0.6679999828338623},{"id":"https://openalex.org/keywords/muramyl-dipeptide","display_name":"muramyl dipeptide","score":0.8309999704360962},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9179999828338623},{"id":"https://openalex.org/keywords/poly-i-c","display_name":"poly(I:C)","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.8702746033668518},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.611895740032196},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5961036682128906},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5290155410766602},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.45860111713409424},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.4390350878238678},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.41108593344688416},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.402793288230896},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3518795967102051},{"id":"https://openalex.org/C16685009","wikidata":"https://www.wikidata.org/wiki/Q335057","display_name":"Andrology","level":1,"score":0.3495429754257202},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.31482499837875366},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3046104609966278},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.10517853498458862},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001798","descriptor_name":"Blood Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002448","descriptor_name":"Cell Adhesion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003470","descriptor_name":"Culture Media","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D009708","descriptor_name":"Nucleotidases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013535","descriptor_name":"Suspensions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015720","descriptor_name":"5'-Nucleotidase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/jlb.43.3.224","doi":"https://doi.org/10.1002/jlb.43.3.224","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jlb.43.3.224","pdf_url":null,"source":{"id":"https://openalex.org/S199011235","display_name":"Journal of Leukocyte Biology","issn_l":"0741-5400","issn":["0741-5400","1938-3673"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Leukocyte Biology","raw_type":"journal-article"},{"id":"pmid:2830357","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2830357","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of leukocyte biology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.544.2767","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.544.2767","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.jleukbio.org/content/43/3/224.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W94534483","https://openalex.org/W98045151","https://openalex.org/W127732268","https://openalex.org/W331950933","https://openalex.org/W1219612158","https://openalex.org/W1530628215","https://openalex.org/W1556236179","https://openalex.org/W1593190845","https://openalex.org/W2013746487","https://openalex.org/W2023702648","https://openalex.org/W2026889550","https://openalex.org/W2028381044","https://openalex.org/W2055386166","https://openalex.org/W2066215389","https://openalex.org/W2083111591","https://openalex.org/W2088311089","https://openalex.org/W2147123300","https://openalex.org/W2148282922","https://openalex.org/W2468684013"],"related_works":["https://openalex.org/W1975086660","https://openalex.org/W2016846887","https://openalex.org/W2138015041","https://openalex.org/W1974440224","https://openalex.org/W1219612158","https://openalex.org/W2057416951","https://openalex.org/W2414565495","https://openalex.org/W4255289030","https://openalex.org/W1940535066"],"abstract_inverted_index":{"Elutriator-purified":[0],"human":[1,29,53,59,140,209],"monocytes":[2,30,45],"were":[3,18,46,57,74,199,220],"cultured":[4,127,191],"in":[5,25,39,109,119,128,160,181,313],"a":[6,91,147,319],"serum-free":[7],"(SF)":[8],"medium,":[9],"and":[10,14,185,196,212,231,259,281],"various":[11],"serum":[12,55,157,179,322],"proteins":[13,323],"functional":[15,272],"activating":[16],"agents":[17],"assessed":[19],"for":[20,123,249,302],"their":[21,120,327],"effects":[22],"on":[23,287],"the":[24,44,64,78,95,156,164,176,247,255,269,288,303,338],"vitro":[26],"maturation":[27,61,68,97,142,166,206,244,263,290,307],"of":[28,36,43,52,66,94,138,155,189,228,254,268,321,341],"to":[31,77,106,152,174,202,222,235,299,305,315,329,336],"macrophages.":[32],"Following":[33],"3":[34,124,136],"days":[35,125,137],"suspension":[37,72,190],"culture":[38,73],"Teflon":[40],"labware,":[41],"60%":[42],"easily":[47],"recovered.":[48],"When":[49,131],"varying":[50],"concentrations":[51],"AB":[54],"(HuAB)":[56],"employed,":[58,90],"monocyte":[60,96,141,165,205,237,271,289,304,332],"progressed":[62],"rapidly;":[63],"kinetics":[65],"this":[67,101,342],"process":[69,98],"during":[70],"cell":[71,110,294],"very":[75],"similar":[76],"pattern":[79],"observed":[80],"following":[81],"adherence":[82,295],"culture.":[83],"In":[84],"contrast,":[85],"when":[86,126],"SF":[87,129],"medium":[88],"was":[89,99,133,172,240],"marked":[92],"retardation":[93],"observed;":[100],"could":[102,116],"not":[103,201,241],"be":[104,117,175,300,337],"attributed":[105],"any":[107],"changes":[108],"recovery":[111],"and/or":[112],"viability.":[113],"Thus,":[114,292],"cells":[115],"maintained":[118],"monocytoid":[121],"form":[122],"medium.":[130],"HuAB":[132,161],"added":[134],"after":[135],"culture,":[139],"into":[143],"macrophages":[144],"proceeded":[145],"at":[146],"normal":[148],"rate.":[149],"We":[150],"attempted":[151],"characterize":[153],"certain":[154],"protein(s)":[158],"found":[159,173],"which":[162],"promoted":[163],"process.":[167,291,308,343],"Human":[168],"immunoglobulin":[169],"G":[170],"(IgG)":[171],"most":[177],"potent":[178,270],"protein":[180],"increasing":[182],"5'-N":[183],"activity":[184,188],"decreasing":[186],"peroxidase":[187],"monocytes.":[192],"Immunoglobulin":[193],"M":[194],"(IgM)":[195],"albumin":[197],"(Alb)":[198],"shown":[200,221],"have":[203,223],"significant":[204],"activity.":[207,265],"Heat-treated":[208],"gamma":[210],"globulin":[211],"IgG":[213,232,256],"purified":[214],"by":[215,326],"high-performance":[216],"liquid":[217],"chromatography":[218],"(HPLC)":[219],"patterns":[224],"identical":[225],"with":[226,233,331],"that":[227,312],"untreated":[229],"HGG":[230],"regard":[234],"promoting":[236,264],"maturation;":[238],"F(ab')2":[239],"an":[242,250],"active":[243],"promoter,":[245],"indicating":[246],"need":[248],"intact":[251],"Fc":[252],"portion":[253],"molecule.":[257],"Fibrinogen":[258],"fibronectin":[260],"also":[261],"had":[262,284],"Finally,":[266],"addition":[267,314],"activators,":[273],"muramyl":[274],"dipeptide":[275],"(MDP),":[276],"polyriboinosinic:polyribocytidilic":[277],"acid":[278],"(Poly":[279],"I:C),":[280],"lipopolysaccharide":[282],"(LPS)":[283],"no":[285],"effect":[286],"neither":[293],"or":[296],"activation":[297],"appear":[298,335],"critical":[301],"macrophage":[306],"Instead,":[309],"we":[310],"hypothesize":[311],"proper":[316],"nutritional":[317],"support,":[318],"group":[320],"(unified":[324],"mainly":[325],"ability":[328],"interact":[330],"membrane":[333],"receptors)":[334],"principal":[339],"promoters":[340]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2186436627","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
